Key information: Sales of €27.1bn, 15% ahead of 2015; up 4% on a pro-forma basis. CRH’s sales €0.9bn lower than consensus. EBITDA up 41% to €3.1bn, ahead of November guidance; pro-forma EBITDA up 10%. EBITDA margin 11.5%, up from 9.4% in 2015. EPS of €1.50, 69% higher than in 2015 and in line with consensus. Cash inflow of €2.3bn from operating activities. Year-end net debt reduced by €1.3bn to €5.3bn. Net debt/EBITDA is 1.7x.
02 Mar 2017
Strong deleveraging, cash flow generation and clever capital allocation
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong deleveraging, cash flow generation and clever capital allocation
CRH public limited company (CRH:LON) | 6,223 -2489.2 (-0.6%) | Mkt Cap: 42,999m
- Published:
02 Mar 2017 -
Author:
Felix Brunotte -
Pages:
4
Key information: Sales of €27.1bn, 15% ahead of 2015; up 4% on a pro-forma basis. CRH’s sales €0.9bn lower than consensus. EBITDA up 41% to €3.1bn, ahead of November guidance; pro-forma EBITDA up 10%. EBITDA margin 11.5%, up from 9.4% in 2015. EPS of €1.50, 69% higher than in 2015 and in line with consensus. Cash inflow of €2.3bn from operating activities. Year-end net debt reduced by €1.3bn to €5.3bn. Net debt/EBITDA is 1.7x.